For disease-free survival (RFS), the results showed that only the high expression of RRP12 in LIHC (hepatocellular carcinoma) had a poor prognosis (p<0.05), and the rest were not statistically significant (Figure 3). The gene discussed is RRP12; the disease is hepatocellular carcinoma.